Projected Earnings Date: 2017-07-04    (Delayed quote data   2025-10-29)
Last
 35.78
Change
 ⇓ -0.89   (-2.43%)
Volume
  329,178
Open
 36.50
High
 36.50
Low
 35.74
8EMA (Daily)
 36.24
40EMA (Daily)
 36.00
50EMA (Daily)
 35.76
STO (Daily)
 73.854
MACD Hist (Daily)
 0.110
8EMA (Weekly)
 36.114
40EMA (Weekly)
 32.27
50EMA (Weekly)
 31.55
STO (Weekly)
 71.049
MACD Hist (Weekly)
 -0.396
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com